Evidence map›Paper›PMID 36756538›Full record

ArticleJournal of biomolecular techniques : JBT2022

Reducing Interferences in Glycosylation Site Mapping.

Lily Birx, Alex Harvey, Marla Popov, Ron Orlando

Abstract read
In one paragraph

Article in Journal of biomolecular techniques : JBT, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lily BirxComplex Carbohydrate Research Center (CCRC) and Departments of Biochemistry and Molecular Biology and Chemistry University of Georgia AthensGeorgia30602 USA.
Alex HarveyGlycoScienti AthensGeorgia30602 USA Viamune AthensGeorgia30602 USA.
Marla PopovGlycoScienti AthensGeorgia30602 USA.
Ron OrlandoComplex Carbohydrate Research Center (CCRC) and Departments of Biochemistry and Molecular Biology and Chemistry University of Georgia AthensGeorgia30602 USA GlycoScienti AthensGeorgia30602 USA.

Funding

Software for Determining Proteoform Heterogeneity and Protein Expression FidelityR44GM131533 · NIGMS · GENNEXT TECHNOLOGIES, INC. · PI WEINBERGER, SCOT RANDY · 2021 to 2023
$1.7M
Development of Isotopically Labeled Glycoproteins for use as Internal StandardsR42GM113666 · NIGMS · GLYCOSCIENTIFIC, LLC · PI ORLANDO, RON · 2020 to 2021
$697k
Targeting aberrant glycopeptide tumor antigens for generation of novel cancer therapeutics with enhanced selectivity and utilityR43GM123919 · NIGMS · VIAMUNE, INC. · PI HARVEY, ALEX JORDAN · 2017 to 2018
$436k
Development of Isotopically Labeled Glycoproteins for use as Internal StandardsR41GM113666 · NIGMS · GLYCOSCIENTIFIC, LLC · PI ORLANDO, RON · 2015 to 2015
$270k
NIGMS NIH HHS R41 GM113666NIGMS NIH HHS R42 GM113666NIGMS NIH HHS R43 GM123919NIGMS NIH HHS R44 GM131533
6 · The paper itself

Abstract

A current method to locate sites of

Indexed as

AsparagineChromatography, LiquidGlycosylationMass SpectrometryPeptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidaseAsparaginePeptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidaseGlycansGlycoproteinglycosylation site mappingLiquid chromatography–mass spectrometry

Identifiers

PMID36756538
PMCPMC9879629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.